Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tae-Hwe Heo

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
International Immunopharmacology|November 5, 2011
Anti-erythropoietin and anti-thrombopoietin antibodies induced after administration of recombinant human erythropoietinSug Kyun Shin, Seung Pil Pack, Jin-Gyo Oh, et al.
Plos One|July 30, 2015
NRF2 Signaling Negatively Regulates Phorbol-12-Myristate-13-Acetate (PMA)-Induced Differentiation of Human Monocytic U937 Cells into Pro-Inflammatory MacrophagesMin-Gu Song, In-Geun Ryoo, Hye-Young Choi, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 6, 2010
Application of a bridging ELISA for detection of anti-erythropoietin binding antibodies and a cell-based bioassay for neutralizing antibodies in human seraSug Kyun Shin, Sung Kyu Ha, Kang Wook Lee, et al.
International Journal of Cancer|October 29, 2002
Both the epitope specificity and isotype are important in the antitumor effect of monoclonal antibodies against Her-2/neu antigenKwang-Mi Kim, Eun-Young Shin, Jeoung-Hyun Moon, et al.
Chemico-Biological Interactions|January 17, 2012
Hepatic expression of cytochrome P450 in type 2 diabetic Goto-Kakizaki ratsSoo Jin Oh, Jong Min Choi, Kang Uk Yun, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2016
Structure-activity relationship study of a series of novel oxazolidinone derivatives as IL-6 signaling blockersSarbjit Singh, Veeraswamy Gajulapati, Kondaji Gajulapati, et al.
British Journal of Pharmacology|July 29, 2025
IA-0130, a novel 3-(1,3-diarylallylidene)oxindole derivative, alleviates ovarian cancer via inhibiting IL-6/gp130/STAT3 signallingSun-Ae Park, Hee Jung Kim, Lee Kyung Kim, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 6, 2020
Direct Binding to NLRP3 Pyrin Domain as a Novel Strategy to Prevent NLRP3-Driven Inflammation and Gouty ArthritisGabsik Yang, Hye E Lee, Su-Jin Moon, et al.
British Journal of Pharmacology|October 8, 2015
Identification of a resveratrol tetramer as a potent inhibitor of hepatitis C virus helicaseSungjin Lee, Kee Dong Yoon, Myungeun Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 31, 2015
A Novel Small-Molecule Inhibitor Targeting the IL-6 Receptor β Subunit, Glycoprotein 130Soon-Sun Hong, Jung Ho Choi, Sung Yoon Lee, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
International Immunopharmacology|November 5, 2011
Anti-erythropoietin and anti-thrombopoietin antibodies induced after administration of recombinant human erythropoietinSug Kyun Shin, Seung Pil Pack, Jin-Gyo Oh, et al.
Plos One|July 30, 2015
NRF2 Signaling Negatively Regulates Phorbol-12-Myristate-13-Acetate (PMA)-Induced Differentiation of Human Monocytic U937 Cells into Pro-Inflammatory MacrophagesMin-Gu Song, In-Geun Ryoo, Hye-Young Choi, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 6, 2010
Application of a bridging ELISA for detection of anti-erythropoietin binding antibodies and a cell-based bioassay for neutralizing antibodies in human seraSug Kyun Shin, Sung Kyu Ha, Kang Wook Lee, et al.
International Journal of Cancer|October 29, 2002
Both the epitope specificity and isotype are important in the antitumor effect of monoclonal antibodies against Her-2/neu antigenKwang-Mi Kim, Eun-Young Shin, Jeoung-Hyun Moon, et al.
Chemico-Biological Interactions|January 17, 2012
Hepatic expression of cytochrome P450 in type 2 diabetic Goto-Kakizaki ratsSoo Jin Oh, Jong Min Choi, Kang Uk Yun, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2016
Structure-activity relationship study of a series of novel oxazolidinone derivatives as IL-6 signaling blockersSarbjit Singh, Veeraswamy Gajulapati, Kondaji Gajulapati, et al.
British Journal of Pharmacology|July 29, 2025
IA-0130, a novel 3-(1,3-diarylallylidene)oxindole derivative, alleviates ovarian cancer via inhibiting IL-6/gp130/STAT3 signallingSun-Ae Park, Hee Jung Kim, Lee Kyung Kim, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 6, 2020
Direct Binding to NLRP3 Pyrin Domain as a Novel Strategy to Prevent NLRP3-Driven Inflammation and Gouty ArthritisGabsik Yang, Hye E Lee, Su-Jin Moon, et al.
British Journal of Pharmacology|October 8, 2015
Identification of a resveratrol tetramer as a potent inhibitor of hepatitis C virus helicaseSungjin Lee, Kee Dong Yoon, Myungeun Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 31, 2015
A Novel Small-Molecule Inhibitor Targeting the IL-6 Receptor β Subunit, Glycoprotein 130Soon-Sun Hong, Jung Ho Choi, Sung Yoon Lee, et al.
Pageof 8